Download PDF
Am J Perinatol 2023; 40(04): 341-347
DOI: 10.1055/a-1877-6491
SMFM Fellowship Series Article

Incidentally Found Midtrimester Shortened Cervical Length: Practice Patterns among American Maternal–Fetal Medicine Specialists

Farrah N. Hussain 
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Zainab Al-Ibraheemi
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Elianna Kaplowitz
2   Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, New York
,
Bijal Parikh
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Kristina Martimucci Feldman 
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Melissa Chu Lam 
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Lois Brustman
1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York
,
Dawnette Lewis
3   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective The management of incidentally found short cervical length (CL) without prior spontaneous preterm birth (PTB) can vary. While most agree on starting vaginal progesterone, management after CL shortens <10 mm varies. The purpose of this study was to elucidate current practice patterns amongst maternal–fetal medicine (MFM) specialists.

Study Design We conducted an online survey of MFM attending physicians and fellows in the United States from May 2019 to April 2020. The primary outcome was management of varying CL based on gestational age. Variations in management were assessed descriptively.

Results There were 236 respondents out of 400 eligible surveyed, with a response rate of 59.2%. Universal CL screening was reported by 93.6% (49.6% abdominal and 44.1% transvaginal). Management of short CL varied based on CL measurement, rather than gestational age at presentation. At CL <10 mm, management included cerclage (17.4–18.7%), vaginal progesterone (41.3–41.7%), or cerclage plus vaginal progesterone (43.4%). Between CL of 10 to 20 mm, the majority (77.4–91.9%) would start vaginal progesterone. At CL 21 to 25 mm, management varied between expectant management (45.5–48.5%) or vaginal progesterone (51.1–52.8%). Suture material used was ethylene terephthalate (47.4%) or polypropelene (31.2). Preoperative antibiotic use was reported by 22.3%, while 45.5% used them only if the amniotic membranes were exposed, and 32.2% reported no antibiotic use. Postoperative tocolytic use varied with 19.3% reporting no use, 32.6% using it always, 8.2% only after significant cervical manipulation, 22.7% after the patient is experiencing symptoms, and 17.6% using it only if the cervix is dilated on exam. After cerclage placement, 44.5% continued CL surveillance.

Conclusion Substantial differences of opinion exist among MFM physicians regarding management of incidentally found short CL in patients without history of PTB. The differences in responses obtained highlight the need for evidence-based guidelines for managing this clinical scenario.

Key Points

  • There is lack of consensus on the management of incidentally found shortened CL.

  • The purpose of this study was to elucidate current trends in CL screening and management.

  • Substantial differences of opinion exist regarding management of incidentally found short CL.

Keywords

preterm birth - short cervix - transvaginal ultrasound - vaginal progesterone - cerclage


Publication History

Received: 01 March 2022

Accepted: 03 June 2022

Accepted Manuscript online:
17 June 2022

Article published online:
05 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Martin JA, Osterman M. Exploring the decline in the singleton preterm birth rate in the United States, 2019-2020. NCHS Data Brief. Accessed January 2021 at: https://www.cdc.gov/nchs/data/databriefs/db430.pdf
    PubMedGoogle Scholar
  • 2 Patel RM, Kandefer S, Walsh MC. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015; 372 (04) 331-340
    CrossrefPubMedGoogle Scholar
  • 3 Prediction and prevention of spontaneous preterm birth: ACOG practice bulletin summary, number 234. Obstet Gynecol 2021; 138 (02) 320-323
    CrossrefPubMedGoogle Scholar
  • 4 Romero R, Conde-Agudelo A, Da Fonseca E. et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol 2018; 218 (02) 161-180
    CrossrefPubMedGoogle Scholar
  • 5 Romero R, Espinoza J, Kusanovic JP. et al. The preterm parturition syndrome. BJOG 2006; 113 (suppl 3): 17-42
    CrossrefPubMedGoogle Scholar
  • 6 Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A. PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011; 38 (03) 272-280
    CrossrefPubMedGoogle Scholar
  • 7 Cetingoz E, Cam C, Sakallı M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011; 283 (03) 423-429
    CrossrefPubMedGoogle Scholar
  • 8 Hassan SS, Romero R, Vidyadhari D. et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38 (01) 18-31
    CrossrefPubMedGoogle Scholar
  • 9 Romero R, Nicolaides K, Conde-Agudelo A. et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206 (02) 124.e1-124.e19
    CrossrefPubMedGoogle Scholar
  • 10 McIntosh J, Feltovich H, Berghella V, Manuck T. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol 2016; 215 (03) B2-B7
    CrossrefPubMedGoogle Scholar
  • 11 Berghella V, Ciardulli A, Rust OA. et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol 2017; 50 (05) 569-577
    CrossrefPubMedGoogle Scholar
  • 12 Enakpene CA, DiGiovanni L, Jones TN, Marshalla M, Mastrogiannis D, Della Torre M. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening. Am J Obstet Gynecol 2018; 219 (04) 397.e1-397.e10
    CrossrefPubMedGoogle Scholar
  • 13 Norwitz ER, Bahtiyar MO, Sibai BM. Defining standards of care in maternal-fetal medicine. Am J Obstet Gynecol 2004; 191 (04) 1491-1496
    CrossrefPubMedGoogle Scholar
  • 14 Statistical Groupings of States and Counties: United States Census Bureau. 2020 . Accessed March 22, 2022 at: https://www2.census.gov/geo/pdfs/reference/GARM/Ch6GARM.pdf
    PubMedGoogle Scholar
  • 15 American College of O. ACOG Practice Bulletin No.142: cerclage for the management of cervical insufficiency. Obstet Gynecol 2014; 123 (2 Pt 1): 372-379
    CrossrefPubMedGoogle Scholar
  • 16 Orzechowski KM, Nicholas SS, Baxter JK, Weiner S, Berghella V. Implementation of a universal cervical length screening program for the prevention of preterm birth. Am J Perinatol 2014; 31 (12) 1057-1062
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Temming LA, Durst JK, Tuuli MG. et al. Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol 2016; 214 (04) 523.e1-523.e8
    CrossrefPubMedGoogle Scholar
  • 18 Cahill AG, Odibo AO, Caughey AB. et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010; 202 (06) 548.e1-548.e8
    CrossrefPubMedGoogle Scholar
  • 19 Werner EF, Han CS, Pettker CM. et al. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011; 38 (01) 32-37
    CrossrefPubMedGoogle Scholar
  • 20 Pramod R, Okun N, McKay D. et al. Cerclage for the short cervix demonstrated by transvaginal ultrasound: current practice and opinion. J Obstet Gynaecol Can 2004; 26 (06) 564-570
    CrossrefPubMedGoogle Scholar